Search results
Here’s Why Parnassus Value Equity Fund Sold BioMarin Pharmaceutical (BMRN)
Insider Monkey via Yahoo Singapore Finance· 1 week agoParnassus Investments, an investment management company, released the “Parnassus Value Equity Fund”...
BioMarin Pharmaceutical Inc. (NASDAQ:BMRN) Shares Could Be 41% Below Their Intrinsic Value Estimate
Simply Wall St. via Yahoo Singapore Finance· 3 weeks agoKey Insights BioMarin Pharmaceutical's estimated fair value is US$142 based on 2 Stage Free Cash...
Mirum Pharmaceuticals (MIRM) Soars 27.3%: Is Further Upside Left in the Stock?
Zacks via Yahoo Singapore Finance· 3 weeks agoMirum Pharmaceuticals (MIRM) saw its shares surge in the last session with trading volume being...
BioMarin Pharmaceutical (NASDAQ:BMRN) shareholders have endured a 15% loss from investing in the...
Simply Wall St. via Yahoo Singapore Finance· 1 month agoIt's easy to match the overall market return by buying an index fund. Active investors aim to buy...
BioMarin Pharmaceutical Inc. (NASDAQ:BMRN) Q1 2024 Earnings Call Transcript
Insider Monkey via Yahoo Singapore Finance· 3 months agoBioMarin Pharmaceutical Inc. (NASDAQ:BMRN) Q1 2024 Earnings Call Transcript April 24, 2024 BioMarin...
BioMarin (BMRN) Down 7.6% Since Last Earnings Report: Can It Rebound?
Zacks via Yahoo Singapore Finance· 2 months agoIt has been about a month since the last earnings report for BioMarin Pharmaceutical (BMRN). Shares...
Insider Sale: EVP, Chief Commercial Officer Jeffrey Ajer Sells 5,000 Shares of Biomarin ...
GuruFocus.com via Yahoo Singapore Finance· 2 months agoOn May 2, 2024, Jeffrey Ajer, the Executive Vice President and Chief Commercial Officer of Biomarin...
Beyond the Balance Sheet: What SWOT Reveals About Biomarin Pharmaceutical Inc (BMRN)
GuruFocus.com via Yahoo Singapore Finance· 2 months agoRobust portfolio of rare-disease therapies with a focus on genetic discovery. Strategic positioning...
Zacks Industry Outlook Highlights BioMarin, Blueprint Medicines, Immunovant, Kymera and Ligand
Zacks via Yahoo Singapore Finance· 2 months agoFor Immediate Release Chicago, IL – May 7, 2024 – Today, Zacks Equity Research discusses BioMarin...
PRIMECAP Management Bolsters Stake in Biomarin Pharmaceutical Inc
GuruFocus.com via Yahoo Singapore Finance· 5 months agoOn the last day of 2023, PRIMECAP Management (Trades, Portfolio) made a notable addition to its...